pharma · Critical Limb Ischemia (CLI) · Sarcoma · DSGN
Lxo Ireland Designated
Lxo Ireland Designated Activity Company
Lxo Ireland Designated is a pharma organization headquartered in CARLSBAD, CA, IE. It trades on NYSE under ticker DSGN. Primary therapeutic focus areas include Critical Limb Ischemia (CLI), Sarcoma, Friedreich Ataxia, HP
CARLSBAD, CA, IE HQ
Public company Type
DSGN · NYSE Ticker
Company details
- Status
- Public
- HQ
- CARLSBAD, CA, IE
- Programs
- 68
- Drugs
- 61
- Patents
- 201
Intracoronary infusion of autologous bone marrow cells
Phase 2 · other · Dilated Cardiomyopathy
Intracoronary infusion of autologous bone marrow cells for Dilated Cardiomyopathy is a Phase 2 program (other) at Lxo Ireland Designated Activity Company with 1 ClinicalTrials.gov record(s).
Internal code TCMR0007/2006
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Lxo Ireland Designated Activity Company
- Phase
- Phase 2
- Modality
- other
- Indication
- Dilated Cardiomyopathy
- Status
- completed
- Trials
- 1